SUZANNE M SHEMA Insider Trading $ONXX ONYX PHARMACEUTICALS INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for SUZANNE M SHEMA.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of SUZANNE M SHEMA. SUZANNE M SHEMA is EVP, General Counsel & Sec in ONYX PHARMACEUTICALS INC ($ONXX) and SVP, General Counsel in ONYX PHARMACEUTICALS INC ($ONXX).
SUZANNE M SHEMA in ONYX PHARMACEUTICALS INC
Trading Symbol: ONXXIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of SUZANNE M SHEMA: EVP, General Counsel & Sec, SVP, General Counsel
Holdings: 44,118 shares
Latest Transaction: Aug 08 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of SUZANNE M SHEMA in ONYX PHARMACEUTICALS INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 35.18 | 12,833 | 451,465 | 25,667 | |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 37.68 | 2,100 | 79,128 | 25,900 | |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 32.07 | 1,344 | 43,102 | 28,909 | |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 30.28 | 656 | 19,864 | 13,125 | |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 71.97 | 14,933 | 1,074,728 | 44,118 | 59.1 K to 44.1 K (-25.29 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 71.79 | 2,000 | 143,580 | 59,051 | 61.1 K to 59.1 K (-3.28 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 35.18 | 12,833 | 451,465 | 61,051 | 48.2 K to 61.1 K (+26.61 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 37.68 | 2,100 | 79,128 | 48,218 | 46.1 K to 48.2 K (+4.55 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 32.07 | 1,344 | 43,102 | 46,118 | 44.8 K to 46.1 K (+3.00 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 30.28 | 656 | 19,864 | 44,774 | 44.1 K to 44.8 K (+1.49 %) |
Aug 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 71.93 | 6,550 | 471,146 | 44,118 | 50.7 K to 44.1 K (-12.93 %) |
Jul 27 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 73.97 | 2,971 | 219,770 | 50,668 | 53.6 K to 50.7 K (-5.54 %) |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 30.28 | 7,719 | 233,731 | 13,781 | |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 32.07 | 16,747 | 537,076 | 30,526 | |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 68.53 | 4,265 | 292,280 | 53,639 | 57.9 K to 53.6 K (-7.37 %) |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 67.49 | 20,201 | 1,363,365 | 57,904 | 78.1 K to 57.9 K (-25.86 %) |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 30.28 | 7,719 | 233,731 | 78,105 | 70.4 K to 78.1 K (+10.97 %) |
Jul 11 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 32.07 | 16,747 | 537,076 | 70,386 | 53.6 K to 70.4 K (+31.22 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 30.28 | 10,000 | 302,800 | 21,500 | |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Option Exercise | M | 32.07 | 30,000 | 962,100 | 47,000 | |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.44 | 10,000 | 444,351 | 53,639 | 63.6 K to 53.6 K (-15.71 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.48 | 10,000 | 444,750 | 63,639 | 73.6 K to 63.6 K (-13.58 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.61 | 10,000 | 446,146 | 73,639 | 83.6 K to 73.6 K (-11.96 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.58 | 4,000 | 178,334 | 83,639 | 87.6 K to 83.6 K (-4.56 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.60 | 3,000 | 133,800 | 87,639 | 90.6 K to 87.6 K (-3.31 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Sell | S | 44.57 | 3,000 | 133,710 | 90,639 | 93.6 K to 90.6 K (-3.20 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 30.28 | 10,000 | 302,800 | 93,639 | 83.6 K to 93.6 K (+11.96 %) |
Jun 08 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | EVP, General Counse ... | Buy | M | 32.07 | 30,000 | 962,100 | 83,639 | 53.6 K to 83.6 K (+55.93 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Option Exercise | A | 37.68 | 28,000 | 1,055,040 | 28,000 | |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Option Exercise | A | 37.68 | 38,200 | 1,439,376 | 38,200 | |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Sell | D | 36.58 | 694 | 25,385 | 53,639 | 54.3 K to 53.6 K (-1.28 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Sell | D | 36.58 | 568 | 20,776 | 54,333 | 54.9 K to 54.3 K (-1.03 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Grant | A | 0.00 | 17,150 | 0 | 54,901 | 37.8 K to 54.9 K (+45.43 %) |
Apr 03 2012 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Grant | A | 0.00 | 7,500 | 0 | 37,751 | 30.3 K to 37.8 K (+24.79 %) |
Sep 02 2011 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Sell | S | 34.14 | 1,353 | 46,191 | 30,251 | 31.6 K to 30.3 K (-4.28 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Option Exercise | A | 35.18 | 38,500 | 1,354,430 | 38,500 | |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Payment of Exercise | F | 35.18 | 550 | 19,349 | 31,604 | 32.2 K to 31.6 K (-1.71 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Grant | A | 0.00 | 12,500 | 0 | 32,154 | 19.7 K to 32.2 K (+63.60 %) |
Apr 04 2011 | ONXX | ONYX PHARMACEUTICA ... | SHEMA SUZANNE M | SVP, General Counse ... | Grant | A | 0.00 | 5,500 | 0 | 19,654 | 14.2 K to 19.7 K (+38.86 %) |
Page: 1